BlackRock Investment Management, LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 64 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2016$99,000
-44.1%
50,3170.0%0.00%
Q3 2016$177,000
-1.7%
50,317
+0.0%
0.00%
Q2 2016$180,000
-11.8%
50,314
+19.1%
0.00%
Q1 2016$204,000
-16.4%
42,241
+2.1%
0.00%
Q4 2015$244,000
-0.4%
41,3760.0%0.00%
Q3 2015$245,000
-57.2%
41,376
-1.7%
0.00%
-100.0%
Q2 2015$573,000
+262.7%
42,082
+240.6%
0.00%
Q1 2015$158,000
+79.5%
12,357
+44.4%
0.00%
Q4 2014$88,0008,5550.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q4 2015
NameSharesValueWeighting ↓
CARL DOMINO INC 58,435$190,0000.18%
VAN DEN BERG MANAGEMENT I, INC 165,900$584,0000.07%
Granite Investment Partners, LLC 141,206$497,0000.04%
ORACLE INVESTMENT MANAGEMENT INC 50,804$179,0000.03%
JW Asset Management, LLC 8,500$30,0000.02%
Psagot Value Holdings Ltd. 55,362$195,0000.01%
Financial Architects, Inc 5,056$18,0000.01%
B. Riley Wealth Advisors, Inc. 48,226$19,0000.00%
Virtu KCG Holdings LLC 43,205$152,0000.00%
Edge Wealth Management LLC 2,000$7,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders